1-1 of 1
Keywords: Receptor tyrosine kinase
Close
Sort by
Journal Articles
Biol Open (2023) 12 (8): bio059994.
Published: 15 August 2023
... underpinnings of cancer biology. Small molecule inhibitors are available for treating ALK , ROS1, RET and NTRK1- rearranged receptor tyrosine kinases (RTKs) in lung cancers, but variable or incomplete responses are often observed and acquired resistance is unavoidable ( Bivona and Doebele, 2016 ; Doebele...
Includes: Supplementary data